Download Full Text (7.5 MB)
- Cellular Studies Guide Scheduling of Ara-C Treatment for Patients with Acute Leukemia
- Potent Noncardiotoxic Drug Proves Effective for Metastatic Breast Cancer
- Factors Affecting Accurate Reading Of CEA Tumor Marker Levels Detailed
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
The University of Texas MD Anderson Cancer Center
Leukemia; Cytarabine; ARA-C; Breast Neoplasms; Neoplasm Metastasis; Biomarkers; Tumor; Tumor Biomarkers; Tumor Marker
History of Science, Technology, and Medicine | Oncology
The University of Texas MD Anderson Cancer Center; Yap, Hwee-Yong MD; Blumenschein, George R. MD; Barnes, Brian C. MD; Schell, Frank C. MD; Bodey, Gerald P. MD; and Fritsche, Herbert A. Jr., PhD, "Oncolog, Volume 28, Number 03, July-September 1983" (1983). OncoLog MD Anderson's Report to Physicians (All issues). 3.